Cryoport Company Insiders
| CYRX Stock | USD 8.23 -0.06 -0.72% |
Cryoport's insiders are aggressively selling. The analysis of insiders' sentiment of trading Cryoport stock suggests that virtually all insiders are panicking at this time. Cryoport employs about 684 people. The company is managed by 12 executives with a total tenure of roughly 31 years, averaging almost 2.0 years of service per executive, having 57.0 employees per reported executive.
| Jerrell Shelton CEO CEO and President and Director |
Insider Sentiment
Mostly Selling
Selling | Buying |
Latest Trades
| 2026-03-16 | Edward J Zecchini | Disposed 2014 @ 8 | View | ||
| 2026-03-12 | Robert Stefanovich | Disposed 38700 @ 7.76 | View | ||
| 2025-12-10 | Ramkumar Mandalam | Disposed 11570 @ 9.99 | View | ||
| 2025-09-11 | Robert J Hariri | Disposed 25000 @ 9.71 | View | ||
| 2025-08-22 | Robert J Hariri | Disposed 5000 @ 8.6 | View | ||
| 2025-08-19 | Robert Stefanovich | Disposed 9300 @ 8.67 | View | ||
| 2025-07-22 | Ramkumar Mandalam | Disposed 40728 @ 7.24 | View | ||
| 2025-06-24 | Jerrell Shelton | Disposed 16344 @ 7.06 | View | ||
| 2025-06-20 | Jerrell Shelton | Disposed 69135 @ 6.47 | View | ||
| 2025-06-18 | Jerrell Shelton | Disposed 119281 @ 6.81 | View | ||
| 2025-06-17 | Jerrell Shelton | Disposed 151304 @ 6.81 | View | ||
| 2025-06-13 | Ramkumar Mandalam | Disposed 624 @ 6.8 | View | ||
| 2025-06-12 | Ramkumar Mandalam | Disposed 1895 @ 7.01 | View | ||
| 2025-06-11 | Ramkumar Mandalam | Disposed 8193 @ 7.06 | View | ||
| 2025-06-10 | Edward J Zecchini | Disposed 51500 @ 6.84 | View | ||
| 2025-06-09 | Ramkumar Mandalam | Disposed 5622 @ 7.06 | View |
Monitoring insider sentiment in Cryoport can give investors another window into how people closest to the business may be assessing current prospects. The stronger workflow is to compare insider behavior with earnings, guidance, and business changes instead of reading the transactions in isolation.
Cryoport | Build portfolio with Cryoport Stock |
Cryoport's Workforce Through the Years
Workforce analysis for Cryoport has become more relevant because employee trends can reveal changes in operating scale, cost pressure, and business confidence. Current projections suggest a workforce around about 680 employees by April 2026, which should be reviewed alongside revenue and margin trends.Macro event markers
Management Team Effectiveness
The company has return on total asset (ROA) of -2.69 % meaning that the return on assets was negative, reflecting a $2.69 loss per $100. This sits far below comparable companies. Similarly, it shows a return on stockholder's equity (ROE) of -7.51 %, suggesting that it is drawing down equity without generating offsetting profit.As of the beginning of March, Common Stock Shares Outstanding is projected to grow to approximately 52.6 M, despite previous gains, Net Loss is estimated to retreat toward about -42.8 M.
Stock Institutional Investors
About 96.14% of Cryoport is held by institutions, with insiders at 3.86%. Current market capitalization is about 415.07 Million. This helps separate index flows from active bets. The business currently sits in the Health Care sector and the Health Care Equipment & Services industry. Watching turnover and volume trends alongside ownership data adds depth to the picture.
| Shares | Deutsche Bank Ag | 2025-09-30 | 994.1 K | Dimensional Fund Advisors, Inc. | 2025-12-31 | 967.6 K | State Street Corp | 2025-09-30 | 963.8 K | Silvercrest Asset Management Group Llc | 2025-12-31 | 840.5 K | Mak Capital One Llc | 2025-09-30 | 818.2 K | Acadian Asset Management Llc | 2025-09-30 | 671.3 K | Bnp Paribas Asset Management (former Axa Im) | 2025-09-30 | 635.1 K | Meros Investment Management, Lp | 2025-12-31 | 626.4 K | Bank Of America Corp | 2025-09-30 | 521.1 K | Cadian Capital Management Lp | 2025-12-31 | 5 M | Morgan Stanley - Brokerage Accounts | 2025-09-30 | 4.6 M |
Insider Trading Activities
Insider activity around Cryoport matters because officers and directors often act on business changes before the market catches up. Most U.S. insider trades appear in Form 4 filings. The value comes from reading the sequence, not one filing in isolation.
Corporate Filings
F4 | 17th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 16th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 5th of March 2026 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 3rd of March 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 17th of February 2026 An amended filing to the original Schedule 13G | ViewVerify |
13A | 5th of February 2026 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 12th of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2025 An amended filing to the original Schedule 13G | ViewVerify |
Shares in Circulation | First Issued 2005-06-30 | Previous Quarter 50.1 M | Current Value 49.8 M | Average Shares Outstanding 19.5 M | Quarterly Volatility 20 M |
Macro event markers
Holders Distribution
Institutional ownership analysis for Cryoport matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the stock quickly once sentiment changes.
Market Cap and Value
Workforce Comparison
Cryoport ranks first in number of employees among leading competitors. The total workforce of Health Care industry is currently estimated at about 18,297. Cryoport holds roughly 684 in number of employees claiming about 4% of equities under Health Care sector.
The company has Profit Margin (PM) of 44.0 %, which indicates that the company has room to navigate competitive or macro headwinds. This ranks above peers on this metric. Similarly, it shows Operating Margin (OM) of -1.0 %, which implies that the company is operating at a deficit of $1.0 per $100 of sales. Insider Trading History
The insider timeline for Cryoport shows how management behavior has tracked against the stock's price over time. Shares outstanding are near 49.9 M. Since insider trades are publicly filed, the record helps verify whether management actions match their words.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 1.3333 | 8 | 6 | 866,408 | 141,798 |
| 2025-09-01 | 0.6364 | 7 | 11 | 236,164 | 316,192 |
| 2025-06-01 | 0.8182 | 18 | 22 | 883,312 | 1,125,783 |
| 2025-03-01 | 0.8462 | 11 | 13 | 214,584 | 35,506 |
| 2024-12-01 | 0.5 | 7 | 14 | 330,835 | 563,521 |
| 2024-09-01 | 0.2 | 1 | 5 | 4,167 | 11,334 |
| 2024-06-01 | 5.0 | 10 | 2 | 183,375 | 11,548 |
| 2024-03-01 | 0.8235 | 14 | 17 | 237,317 | 196,967 |
| 2023-09-01 | 0.6 | 3 | 5 | 71,000 | 99,375 |
| 2023-06-01 | 2.8 | 14 | 5 | 445,675 | 474,575 |
| 2023-03-01 | 1.0 | 10 | 10 | 165,469 | 26,158 |
| 2022-06-01 | 3.4 | 17 | 5 | 154,200 | 13,540 |
| 2022-03-01 | 1.25 | 10 | 8 | 188,522 | 65,060 |
| 2021-12-01 | 0.2759 | 8 | 29 | 195,418 | 1,390,836 |
| 2021-09-01 | 0.3571 | 10 | 28 | 205,316 | 1,046,036 |
| 2021-06-01 | 0.8667 | 26 | 30 | 232,753 | 1,595,708 |
| 2021-03-01 | 1.5263 | 29 | 19 | 2,978,966 | 518,098 |
| 2020-12-01 | 1.0 | 6 | 6 | 112,029 | 142,652 |
| 2020-09-01 | 2.0 | 4 | 2 | 23,870 | 23,438 |
| 2020-06-01 | 5.0 | 10 | 2 | 186,257 | 16,668 |
| 2020-03-01 | 1.75 | 7 | 4 | 560,600 | 89,562 |
| 2019-12-01 | 0.5833 | 7 | 12 | 149,657 | 305,072 |
| 2019-03-01 | 2.0 | 6 | 3 | 104,490 | 70,321 |
| 2018-12-01 | 3.0 | 6 | 2 | 61,747 | 30,000 |
| 2018-09-01 | 1.0 | 4 | 4 | 31,386 | 60,000 |
| 2018-06-01 | 1.6667 | 10 | 6 | 170,396 | 33,491 |
| 2018-03-01 | 1.75 | 7 | 4 | 476,835 | 147,854 |
| 2017-09-01 | 1.0 | 2 | 2 | 1,762 | 21,396 |
| 2016-03-01 | 2.3333 | 7 | 3 | 1,012,006 | 844,148 |
| 2015-12-01 | 14.0 | 14 | 1 | 1,431,772 | 0.00 |
| 2015-09-01 | 8.0 | 8 | 1 | 57,602 | 15,300 |
| 2014-12-01 | 6.0 | 12 | 2 | 6,061,539 | 37,503 |
| 2014-06-01 | 2.5 | 5 | 2 | 286,210 | 0.00 |
| 2014-03-01 | 0.3333 | 1 | 3 | 200,000 | 275,000 |
| 2013-12-01 | 0.5 | 3 | 6 | 385,000 | 795,556 |
| 2013-06-01 | 4.0 | 4 | 1 | 6,048,577 | 500,000 |
| 2012-12-01 | 4.0 | 8 | 2 | 2,375,000 | 0.00 |
| 2011-06-01 | 2.0 | 2 | 1 | 250,000 | 125,000 |
| 2010-09-01 | 10.0 | 10 | 1 | 2,006,232 | 100,000 |
Notable Stakeholders
Reviewing the stakeholders around Cryoport can help investors understand which people or institutions may influence direction, governance, and strategic pressure. The practical value is that investors can see where interests align, where they conflict, and how that tension could influence execution.
| Jerrell Shelton | CEO and President and Director | Profile | |
| Robert Stefanovich | CFO, Treasurer, Corporate Secretary | Profile | |
| Robert MS | CFO Treasurer | Profile | |
| Thomas Heinzen | Vice Relations | Profile | |
| Tony Ippolito | VP Counsel | Profile | |
| Phil Wilson | LLC Systems | Profile | |
| Edward Zecchini | Senior Officer | Profile | |
| Mark Sawicki | Senior Officer | Profile | |
| Raymond MD | Ex Officer | Profile | |
| Bret Bollinger | LLC Systems | Profile | |
| David MD | Ex Officer | Profile | |
| Kylie Crowe | Vice Development | Profile |
Management Information & Data Sources
Cryoport is a small-cap company in Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Insider participation may help assess long-term alignment, especially during strategy transitions. CEO is Jerrell Shelton with 684 employees and 12 reported executives.
Macroaxis compiles Cryoport metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Analyst inputs may be included when coverage is available. Not all fields update in real time. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Workforce metrics tied to Cryoport offer a useful way to test whether headcount and economic output are moving in a productive direction. The stronger interpretation compares these measures with sector norms because labor intensity varies meaningfully across industries.
Cryoport Manpower Efficiency
Return on Cryoport Manpower
| Revenue Per Employee | 257.6K | |
| Revenue Per Executive | 14.7M | |
| Net Income Per Employee | 102.8K | |
| Net Income Per Executive | 5.9M | |
| Working Capital Per Employee | 376K | |
| Working Capital Per Executive | 21.4M |
Popular Tools for Cryoport Stock analysis
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |